Nasdaq ETFs

A look at the weighted underlying holdings of the SPDR— S&P— Pharmaceuticals ETF (XPH) shows an impressive 11.4% of holdings on a weighted basis have experienced insider buying within the past six months. Axsome Therapeutics Inc (Symbol: AXSM), which makes up 3

For investors seeking momentum, ALPS Medical Breakthroughs ETF SBIO is probably on radar. The fund just hit a 52-week high, and is up about 107% from its 52-week low price of $25.10/share.But are more gains in store for this ETF? Let’s take a quick look at the fund and the near

United Bankshares Inc (Symbol: UBSI) has been named to the Dividend Channel ''S.A.F.E. 25'' list, signifying a stock with above-average ''DividendRank'' statistics including a strong 4.6% yield, as well as a superb track record of at least two decades of dividend growth, accord

Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itsel

In recent trading, shares of Bio-Rad Laboratories Inc (Symbol: BIO) have crossed above the average analyst 12-month target price of $560.00, changing hands for $567.26/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgra

To become a "Dividend Aristocrat," a dividend paying company must accomplish an incredible feat: consistently increase shareholder dividends every year for at least 20 consecutive years. Companies with this kind of track record tend to attract a lot of investor attention —

In recent trading, shares of Omega Healthcare Investors, Inc. (Symbol: OHI) have crossed above the average analyst 12-month target price of $37.36, changing hands for $37.59/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: d

In recent trading, shares of CubeSmart (Symbol: CUBE) have crossed above the average analyst 12-month target price of $32.60, changing hands for $32.91/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation,

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with BlackRock Inc (Symbol: BLK). The average 12-month price target for BLK — averaging the work of 9 analysts — reveals an average price target of $672.78/share.

In recent trading, shares of Coupa Software Inc (Symbol: COUP) have crossed above the average analyst 12-month target price of $316.76, changing hands for $318.43/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on

In recent trading, shares of j2 Global Inc (Symbol: JCOM) have crossed above the average analyst 12-month target price of $100.27, changing hands for $100.50/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on val

In recent trading, shares of Verisk Analytics Inc (Symbol: VRSK) have crossed above the average analyst 12-month target price of $192.92, changing hands for $193.99/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Ares Capital Corp (Symbol: ARCC). The average 12-month price target for ARCC — averaging the work of 13 analysts — reveals an average price target of $15.79/

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with SpringWorks Therapeutics Inc (Symbol: SWTX). The average 12-month price target for SWTX — averaging the work of 4 analysts — reveals an average price target

Analyst ratings can sometimes be complicated, and we here at ETF Channel have noticed a bit of a paradox with Fair Isaac Corp (Symbol: FICO). The average 12-month price target for FICO — averaging the work of 6 analysts — reveals an average price target of $480.50/sh

Last week was downbeat for Wall Street with the S&P 500, the Dow Jones and the Nasdaq Composite losing about 1%, 0.6% and 0.7%, respectively. Uncertainty regrading the upcoming Fed meeting, renewed U.S.-China trade tensions and rising virus cases weighed on market sentiments.

By Matt Wagner, CFA, Senior Research Analyst, WisdomTree This has been a whirlwind year in countless ways. The usually staid topic of dividend announcements has even had its fireworks, with significant dividend cuts made from a diverse set of household names like Wells Fargo, Boeing and Disney. S&P 500 dividends per share in 2019 set a record of [...] Read more at ETFtrends.com.

MIDSTREAM RISES LAST WEEK WHILE RENEWABLES LAG Last week, the Alerian MLP ETF (AMLP) surged over 9% on the heels of a 16% gain from its Gathering & Processing MLPs. Crude oil gained roughly 2% last week after OPEC + (Organization of the Petroleum Exporting Cooperation + Russia) agreed to a smaller than expected increase [...] Read more at ETFtrends.com.

By Kevin Flanagan, Head of Fixed Income Strategy, WisdomTree Can you believe it? Last week’s jobs report is the last one to be released in 2020. With the second wave of COVID-19 picking up momentum of late, the tenor of future U.S. economic data could very well begin to show some of the adverse effects. Although [...] Read more at ETFtrends.com.

Five years after the Paris Agreement, carbon intensive corporation’s capex still dwarfs clean energy investment. Five years ago, the Paris climate agreement was signed. At the time, Climate Action Tracker found that existing policies put the world on track to be 3.6°C hotter by 2100 compared to pre-industrial times.[1] While many countries pledged to strengthen [...] Read more at ETFtrends.com.